📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial. (2018)

First Author: Kehoe PG

Attributed to: The MRC ConDuCT-II Hub. COllaboration and iNnovation in DiffiUlt and Complex randomised controlled Trials In Invasive procedures funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3233/jad-170101

PubMed Identifier: 29226862

Publication URI: http://europepmc.org/abstract/MED/29226862

Type: Journal Article/Review

Volume: 61

Parent Publication: Journal of Alzheimer's disease : JAD

Issue: 2

ISSN: 1387-2877